Rechallenge and retreatment with topical imiquimod 5% in transplant recipients: A multicenter experience on actinic keratoses and basal cell carcinomas

• Main Authors: Paolo Fava (Author), Gabriele Roccuzzo (Author), Nicole Macagno (Author), Francesco Cavallo (Author), Valentina Celoria (Author), Gianluca Avallone (Author), Elisa Zavattaro (Author), Federica Veronese (Author), Luigi Biancone (Author), Paola Savoia (Author), Pietro Quaglino (Author)
• Format: Book
• Published: Wiley, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Solid organ transplant recipients (SOTRs) have an increased risk of developing non melanoma skin cancers (NMSCs). The use of Imiquimod, a toll‐like‐receptor agonist, is still debated in SOTRs. Objectives The aim of this study was to evaluate efficacy and safety of topical Imiquim...